Shareholders of Novoprotein, Heze Qiaobei and Shanghai Pujin, plan to reduce their holdings by no more than 0.61% of the shares
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, Novoprotein announced that its shareholders Heze Qiaobei and Shanghai Pujin plan to reduce their holdings in the company through centralized bidding and block trading due to their own operational development and funding needs. Among them, Heze Qiaobei plans to reduce its holdings by no more than 162,000 shares (with a planned reduction ratio of no more than 0.2308%), while Shanghai Pujin plans to reduce its holdings by no more than 263,200 shares (with a planned reduction ratio of no more than 0.3750%)
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments